Literature DB >> 14712133

Disseminated pulmonary candidiasis complicating hyperimmunoglobulin E (Job's) syndrome.

Erkan Yilmaz1.   

Abstract

Hyperimmunoglobulin E (Job's) syndrome is a rare disease characterized by recurrent pneumonia and sinusitis, pneumatoceles, chronic dermatitis, and elevated serum levels of immunoglobulin E. In this report, the author presents a case of disseminated pulmonary candidiasis in a young man with hyperimmunoglobulin E syndrome. His chest radiograph showed reticulonodular opacities in both lungs. Computed tomography scans revealed multiple pulmonary nodules and hilar and mediastinal enlarged lymph nodes.

Entities:  

Mesh:

Year:  2004        PMID: 14712133     DOI: 10.1097/00005382-200401000-00010

Source DB:  PubMed          Journal:  J Thorac Imaging        ISSN: 0883-5993            Impact factor:   3.000


  5 in total

1.  Pneumocystis jirovecii pneumonia in a baby with hyper-IgE syndrome.

Authors:  Ben Zion Garty; Adit Ben-Baruch; Asaf Rolinsky; Cristina Woellner; Bodo Grimbacher; Nufar Marcus
Journal:  Eur J Pediatr       Date:  2009-03-24       Impact factor: 3.183

2.  Recurrent hemoptysis with Penicillium marneffei and Stenotrophomonas maltophilia in Job's syndrome.

Authors:  Bosco H M Ma; Calvin S H Ng; Rebecca K Y Lam; Song Wan; Innes Y P Wan; Tak Wai Lee; Anthony P C Yim
Journal:  Can Respir J       Date:  2009 Jul-Aug       Impact factor: 2.409

Review 3.  Fungal infections in primary immunodeficiencies.

Authors:  Charalampos Antachopoulos; Thomas J Walsh; Emmanuel Roilides
Journal:  Eur J Pediatr       Date:  2007-06-06       Impact factor: 3.183

Review 4.  The hyperimmunoglobulin E syndrome--clinical manifestation diversity in primary immune deficiency.

Authors:  Aleksandra Szczawinska-Poplonyk; Zdzislawa Kycler; Barbara Pietrucha; Edyta Heropolitanska-Pliszka; Anna Breborowicz; Karolina Gerreth
Journal:  Orphanet J Rare Dis       Date:  2011-11-15       Impact factor: 4.123

Review 5.  Hyperimmunoglobulin E syndrome: Genetics, immunopathogenesis, clinical findings, and treatment modalities.

Authors:  Hassan Hashemi; Masoumeh Mohebbi; Shiva Mehravaran; Mehdi Mazloumi; Hamidreza Jahanbani-Ardakani; Seyed-Hossein Abtahi
Journal:  J Res Med Sci       Date:  2017-04-26       Impact factor: 1.852

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.